Identification of a Wnt/β-catenin signaling pathway in human thyroid cells

beta -Catenin is a structural component of the adherens junctions. Outside the adherens junctions a complex consisting of glycogen synthase kinase 3 beta, the tumor suppressor adenomatous polyposis coli, and axin constantly targets beta -Catenin for degradation to keep levels of free beta -Catenin low. Free beta -Catenin is able to bind to transcription factors of the T cell factor/lymphoid-enhancing factor family and to stimulate transcription of target genes. This signaling function of beta -Catenin is activated by extracellular Wnt factors that bind to Frizzled receptors and induce inhibition of beta -Catenin degradation. By RT-PCR and subcloning, we observed the expression of five Wnt factors, three members of the Frizzled receptor family, and all known Disheveled isoforms in thyroid cells. Immunoprecipitation studies demonstrated the formation of the complex targeting beta -Catenin for degradation. Introduction of a degradation resistant beta -Catenin into the thyroid carcinoma cell line WRO induced appearance of monomeric beta -Catenin as shown by size fractionation and nuclear beta -Catenin immunostaining. Reporter gene assays demonstrated a stimulation of T cell factor/lymphoid-enhancing factor-mediated transcription in these cells. In ARO cells, a thyroid carcinoma cell line carrying a mutated adenomatous polyposis coli gene, monomeric beta -Catenin and nuclear immunostaining were observed. In summary, our data indicate that elements of the Wnt signaling pathway are expressed in thyroid cells and that this pathway is functionally active.